Validation of histone deacetylase 3 as a therapeutic target in castration‐resistant prostate cancer - Concepedia

Concepedia

Publication | Closed Access

Validation of histone deacetylase 3 as a therapeutic target in castration‐resistant prostate cancer

32

Citations

41

References

2017

Year

Abigail B. McLeod, James P. Stice, Suzanne E. Wardell, Holly M. Alley, Ching‐yi Chang, Donald P. McDonnell

Abstract

Our studies provide strong rationale for the near-term development of specific HDAC3 inhibitors for the treatment of CRPC.

References

	Year	Citations

Page 1